STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Butterfly Network Inc Stock Price, News & Analysis

BFLY NYSE

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Butterfly Network Inc (NYSE: BFLY) pioneers accessible medical imaging solutions through its revolutionary Ultrasound-on-Chip™ technology. This dedicated news hub provides investors and healthcare professionals with essential updates on product innovations, financial developments, and strategic initiatives driving the future of point-of-care diagnostics.

Discover official press releases covering earnings announcements, regulatory milestones, and partnerships advancing AI-powered ultrasound technology. Our curated collection ensures timely access to verified information about BFLY's handheld imaging systems, educational programs, and market expansion efforts.

Key updates include product launch details, clinical validation studies, and executive leadership changes. Bookmark this page to monitor how Butterfly Network's cloud-connected devices and ScanLab™ training tools continue transforming medical imaging accessibility worldwide.

Rhea-AI Summary

Butterfly Network's iQ3™ handheld ultrasound device has won the Best Medical Technology Award at the 2024 Prix Galien USA Awards, often referred to as the 'Nobel Prize of Life Sciences.' The third-generation device, built on Butterfly's proprietary P4.3 semiconductor platform, represents a significant advancement in ultrasound technology with enhanced AI-powered features and digital image capture capabilities. The company's Ultrasound-on-Chip™ technology aims to make ultrasound imaging more affordable, sustainable, and scalable, leveraging Moore's Law to deliver increasingly powerful and cost-effective imaging tools.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.94%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld ultrasound technology, has announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024, in New York City. CEO Joseph DeVivo and CFO Heather Getz will conduct one-on-one meetings throughout the event. DeVivo will present a business overview at 11:00 am ET. The presentation will be available via webcast on the company's investor website until February 19, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.67%
Tags
conferences
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) reported strong Q3 2024 results with revenue of $20.6 million, up 33% year-over-year. The company reduced its net loss by 38% and net cash used in operations by 50%. Product revenue increased 55% to $13.5 million, while software and services revenue grew 5% to $7.0 million. The company launched iQ3 in Europe and expanded into Indonesia, the Netherlands, and Belgium. Based on strong performance, Butterfly raised its full-year 2024 guidance to $79-81 million in revenue and improved its adjusted EBITDA loss forecast to $42-40 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.04%
Tags
Rhea-AI Summary

HeartFocus has launched its AI-powered Education app in partnership with Butterfly Network (NYSE: BFLY), designed to teach healthcare practitioners how to conduct clinical-grade heart scans using Butterfly's handheld ultrasound devices. The app helps users master 10 essential cardiac views through personalized, AI-powered learning pathways.

Compatible with Butterfly iQ3 and iQ+ probes on iOS iPads, the platform features advanced gamification for enhanced engagement. The app will be demonstrated at the ANCC MagPath 2024 conference and is currently available in the US and 22 other countries, with a -time offer of a free six-month license.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
AI
-
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY), a digital health company specializing in portable, semiconductor-based ultrasound technology, has announced its plans to report third quarter 2024 financial results on November 1, 2024, at 8:00 am ET. The company will host a conference call and webcast before market opening, featuring Joseph DeVivo, President, CEO, and Chairman of the Board, along with Heather Getz, EVP and CFO/COO.

The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website. Interested parties can also dial in to listen to the call. A replay of the call will be available until November 15, 2024, through various access methods provided in the announcement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.14%
Tags
conferences earnings
-
Rhea-AI Summary

Kansas City University (KCU) is pioneering point-of-care ultrasound (POCUS) education by introducing a first-of-its-kind, hands-on POCUS elective in its 2024 curriculum. KCU is the first U.S. medical school to use Butterfly Network's AI-guided ScanLab™ application as the foundation of its POCUS curriculum. The program focuses on student scanning proficiency, ensuring graduates are prepared for residency and clinical settings.

The AI-powered ScanLab™ app provides real-time feedback, anatomical labeling, and grading, enabling students to learn independently. Nearly 300 students have enrolled in KCU's POCUS elective series, using personal Butterfly handheld ultrasound devices. This innovative approach addresses the gap in POCUS training in medical schools, setting a new standard for medical education in the 21st century.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
AI
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) has published a case study highlighting the successful implementation of its point-of-care ultrasound (POCUS) devices and Compass™ workflow software at the University of Rochester Medical Center (URMC). The deployment resulted in a 116% increase in ultrasound charge capture across the health system. URMC has deployed 862 Butterfly devices across 64 departments and plans to scale to 2,500 devices by 2026.

Key achievements include:

  • Nearly 50,000 scanning sessions completed since 2022
  • 74% increase in scanning sessions in 2023
  • 147% rise in studies uploaded from Butterfly devices
  • 1,782% jump in images uploaded from non-Butterfly devices

These results have contributed to earlier diagnoses and improved patient outcomes while reducing emergency visits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.92%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE:BFLY) has been named one of 2024's Fierce 50 honorees by Fierce Life Sciences and Fierce Healthcare. This recognition highlights Butterfly's advancements in medical imaging through its portable, semiconductor-based ultrasound technology. Key achievements include:

1. The successful launch of the next-generation Butterfly iQ3™
2. Establishment of the Butterfly Garden™ program for ultrasound AI innovation
3. Creation of a chip-licensing program for partners to develop technologies Powered by Butterfly™

CEO Joseph DeVivo emphasized the company's mission to democratize medical imaging by improving access, affordability, and sustainability. The Fierce 50 recognition underscores Butterfly's role in driving digital revolution in the ultrasound industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.41%
Tags
none
-
Rhea-AI Summary

Butterfly Network Inc. (NYSE: BFLY) has launched its third-generation handheld point-of-care ultrasound system, Butterfly iQ3™, in Europe. The device, built on advanced Ultrasound-on-Chip™ technology, offers improved image quality, new 3D imaging capabilities, and a smaller, lighter design. Key features include:

1. Unparalleled image quality with twice the processing power of its predecessor
2. Novel tools: iQ Slice™ and iQ Fan™ for advanced 3D imaging
3. Ergonomic design: 17% smaller probe face, 7% shorter probe, and 2.5x faster charging
4. CE marked and EU MDR certified

The Butterfly iQ3 is now available in 16 European countries, expanding the company's mission to democratize ultrasound technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.89%
Tags
none
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld, whole-body ultrasound and intuitive software, has announced its participation in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference. The event is scheduled for September 12, 2024, in New York City.

Heather Getz, Chief Financial and Operations Officer at Butterfly Network, will be representing the company in one-on-one investor meetings during the conference. This participation provides an opportunity for Butterfly Network to showcase its innovative technology and growth potential to investors.

Interested parties can schedule meetings with Heather Getz through their Lake Street representatives, offering a chance for in-depth discussions about the company's future prospects and strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.89%
Tags
conferences

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $2.22 as of November 10, 2025.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 563.3M.
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

563.30M
194.08M
13.92%
48.05%
7.54%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON